SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Eris Lifesciences

BSE: 540596 30 Sep 2025
Healthcare
₹ 1660
Eris Lifesciences Limited specializes in Pharmaceuticals within the Healthcare sector.

Eris Lifesciences - Share Price & Details

Market Cap
₹21,597
High /Low
1,910 / 1,097
Stock P/E
55.8
Book Value
₹210.0
Dividend Yield
0.46
ROCE
12.2
ROE
₹12.9
Face Value
1.0
PEG Ratio
-11.3
EVEBITDA
₹22.4
Debt
2,478
CMP / FCF
90.3
Debt to equity
₹0.87
NP Ann
375
High price all time
1,910
Piotroski score
₹6.0
Graham Number
366.0
No. Eq. Shares
13.6
Net CF
₹105
Net profit
411
Price to book value
7.56
Interest Coverage
₹3.44
Low price all time
321.0
Industry PE
33.0
Reserves
₹2,841
Free Cash Flow
₹910

Broker Recommendations

Date Author Type Reco Price Target Price Potential Source PDF Link
07 Aug 2025 Motilal Oswal Hold ₹0 ₹2,600 8.6% moneycontrol View
06 Aug 2025 Prabhudas Lilladher Buy ₹1,809 ₹1,975 14.5% moneycontrol View
06 Aug 2025 Motilal Oswal Hold ₹1,725.45 ₹1,700 -1.4% moneycontrol View
20 May 2025 Prabhudas Lilladher Buy ₹1,468.75 ₹1,740 15.5% moneycontrol View
19 May 2025 Motilal Oswal Hold ₹1,443.45 ₹1,350 -8.1% moneycontrol View
05 Feb 2025 Prabhudas Lilladher Buy ₹1,231.55 ₹1,450 4.3% moneycontrol View
04 Feb 2025 Motilal Oswal Hold ₹1,231.55 ₹1,270 -12.6% moneycontrol View
26 Oct 2024 Prabhudas Lilladher Buy ₹1,293.2 ₹1,420 -2.8% moneycontrol View
05 Aug 2024 Prabhudas Lilladher Buy ₹1,078.65 ₹1,250 -15% moneycontrol View
22 May 2024 Prabhudas Lilladher Buy ₹908.15 ₹1,100 -25.2% moneycontrol View
14 Mar 2024 Motilal Oswal Hold ₹863.5 ₹930 -36.7% moneycontrol View
23 Feb 2024 Prabhudas Lilladher Buy ₹875.95 ₹1,100 -25.2% moneycontrol View

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
Eris Lifesciences Limited6013.2999.95786.47.3321,59755.8
POLY MEDICURE LTD.4251.42879.293840.478.671985555.5
NEULAND LABORATORIES LTD.3006.09137.082927.5310.6817918136.0

Peer Comparison Chart


About Eris Lifesciences

Eris Lifesciences Limited, with Security Code 540596, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

The total return for Eris Lifesciences (NSE:ERIS) investors has risen faster than earnings growth over the last five years

(18 Sep 2025)
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company...
Read more →

Is Eris Lifesciences Limited (NSE:ERIS) Worth ₹1.8k Based On Its Intrinsic Value?

(01 Sep 2025)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Eris Lifesciences fair value estimate is ₹1365 Eris...
Read more →

Eris Lifesciences Slapped Rs 17 Crore GST Notice Over Novartis Zomelis Deal

(30 Aug 2025)
New Delhi: Eris Lifesciences Limited has disclosed that it has received a show cause-cum-demand notice amounting to Rs16.84 crore from the...
Read more →

Eris Lifesciences receives ANVISA approval at its Ahmedabad campus

(25 Aug 2025)
Eris Lifesciences Limited, a leading Indian branded formulations manufacturing company, today announced that a manufacturing unit in its...
Read more →

Eris Lifesciences Gets ANVISA Approval for Ahmedabad Unit

(25 Aug 2025)
Eris Lifesciences Ltd said a manufacturing unit at its Ahmedabad campus has received clearance from ANVISA, the national health regulator of...
Read more →

Eris Lifesciences' Ahmedabad-based unit gets regulatory approval from Brazil's ANVISA

(25 Aug 2025)
Eris Lifesciences said that its manufacturing unit at the company's Ahmedabad campus has received approval from ANVISA, which is Brazil's...
Read more →